TwinBeech Capital’s Guardant Health GH Stock Holding History

TwinBeech Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52,464	Closed	-$2.73M	–	665
2025 Q2	$2.73M	Buy	+52,464	New	+$2.34M	0.06%	279
2025 Q1	–	Sell	-12,001	Closed	-$367K	–	803
2024 Q4	$367K	Buy	+12,001	New	+$338K	0.01%	495
2024 Q3	–	Sell	-50,740	Closed	-$1.47M	–	752
2024 Q2	$1.47M	Buy	+50,740	New	+$1.18M	0.03%	366
2024 Q1	–	Sell	-29,775	Closed	-$805K	–	675
2023 Q4	$805K	Buy	+29,775	New	+$781K	0.01%	508
2023 Q2	–	Sell	-288,256	Closed	-$6.76M	–	700
2023 Q1	$6.76M	Sell	288,256 -20,678	-7%	-$591K	0.14%	199
2022 Q4	$8.4M	Buy	+308,934	New	+$14.1M	0.16%	170
2022 Q2	–	Sell	-28,588	Closed	-$1.89M	–	580
2022 Q1	$1.89M	Buy	+28,588	New	+$1.96M	0.08%	254

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TwinBeech Capital's GH Position: Q3 2025 in Review

TwinBeech Capital sold out of Guardant Health (GH) in Q3 2025, closing a stake of 52,464 shares — an estimated $2.73M sold.

TwinBeech Capital first reported a position in GH in Q1 2022 and held it in 7 quarters. The position peaked at $8.4M in Q4 2022. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

TwinBeech Capital reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
TwinBeech Capital sold 52,464 Guardant Health shares in Q3 2025, an estimated $2.73M.
TwinBeech Capital first reported a position in Guardant Health in Q1 2022 and held it in 7 quarters.
TwinBeech Capital's Guardant Health position peaked at $8.4M in Q4 2022.
395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on TwinBeech Capital's 13F filing for Q3 2025, filed 14 Nov 2025.